Drug Type Antibody drug conjugate (ADC) |
Synonyms TJ 101, TJ101 |
Target |
Action inhibitors, antagonists |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 1 | China | - | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | China | - |